Mass spectrometry and illicit drug testing: Analytical challenges of the anti-doping laboratories

Expert Review of Proteomics

Volumn 5, Issue 4, 2008, Pages 535-539

  Botrè, Francesco ^a,b  

^a FMSI   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CANNABINOID; CHORIONIC GONADOTROPIN; DIURETIC AGENT; GLUCOCORTICOID; ILLICIT DRUG; STEROID HORMONE; TESTOSTERONE; XENOBIOTIC AGENT;

ANALYTIC METHOD; ATHLETE; DOPING; EDITORIAL; EXTRACTION; FORENSIC IDENTIFICATION; GAS CHROMATOGRAPHY; HUMAN; LABORATORY DIAGNOSIS; LABORATORY TEST; LIQUID CHROMATOGRAPHY; LOCAL ANESTHESIA; MASS SPECTROMETRY; SCIENTIST; SCREENING;

DOPING IN SPORTS; HUMANS; LABORATORIES; MASS SPECTROMETRY; SUBSTANCE ABUSE DETECTION;

EID: 51149087915     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/14789450.5.4.535     Document Type: Editorial

References (23)

1. Trout GJ, Kazlauskas R. Sport drugs testing - an analyst's perspective. Chem. Soc. Rev. 33, 1 (2004).
2. Cowan DA, Kicman AT. Doping in sport: misuse, analytical tests, and legal aspects. Clin. Chem. 43, 1110 (1997).
3. Segura J. Sports. In: Drug Abuse Handbook. Karch SB (Ed.). CRC Press, FL, USA 641-726 (1998).
4. Botrè F. New and old challenges of sports drug testing. J. Mass Spectrom. 43, 903-907 (2008).
5. Hemmersbach P. History of mass spectrometry at the olympic games. J. Mass Spectrom. 43, 839-853 (2008).
6. Hemmersbach P, de la Torre R. Stimulants, narcotics and β-blockers: 25 years of development in analytical techniques for doping control. J. Chromatogr. B 687, 221-238 (1996).
7. Donike M, Barwald K-R, Klostermann K, Schänzer W, Zimmermann J. Nachweis von exogenen testosteron. In: Sport: Leistung und Gesundheit. Heck H, Hollmann W, Liesen H, Rost R (Eds). Deutscher Arzte Verlag, Köln, Germany 293-300 (1983).
8. Cawley AT, Hine ER, Trout GJ, George AV, Kazlauskas R. Searching for new markers of endogenous steroid administration in athletes: "looking outside the metabolic box". Forensic Sci. Intern. 143, 103-114 (2004).
9. 13C-values of endogenous urinary steroids. Steroids 73, 408-416 (2008).
10. Catlin DH, Ahrens BD, Kucherova Y. Detection of norbolethone, an anabolic steroid never marketed, in athletes' urine. Rapid Commun. Mass Spectrom. 16, 1273-1275 (2002).
11. Catlin DH, Sekera MH, Ahrens BD, Starcevic B, Chang YC, Hatton CK. Tetrahydrogestrinone: discovery, synthesis, and detection in urine. Rapid Commun. Mass Spectrom. 18, 1245 (2004).
12. Sekera MH, Ahrens BD, Chang YC, Starcevic B, Georgakopoulos C, Catlin DH. Another designer steroid: discovery, synthesis, and detection of 'Madol' in urine. Rapid Commun. Mass Spectrom. 19, 781 (2005).
13. Thevis M, Kamber M, Schänzer W. Screening for metabolically stable aryl-propionamide-derived selective androgen receptor modulators for doping control purposes. Rapid Commun. Mass Spectrom. 20, 870 (2006).
14. Thevis M, Geyer H, Mareck U, Schänzer W. Screening for unknown synthetic steroids in human urine by liquid chromatography-tandem mass spectrometry. J. Mass Spectrom. 40, 955 (2005).
15. Mazzarino M, Turi S, Botrè F. A screening method for the detection of synthetic glucocorticosteroids in human urine by liquid chromatography-mass spectrometry based on class-characteristic fragmentation pathways. Anal. Bioanal. Chem. 390, 1389 (2008).
16. Georgakopoulos C, Vonaparti A, Stamou M et al. Preventive doping control analysis: liquid and gas chromatography time-of-flight mass spectrometry for detection of designer steroids. Rapid Commun. Mass Spectrom. 27, 2439 (2007).
17. Barroso O, Mazzoni I, Rabin O. Hormone abuse in sports: the antidoping perspective. Asian J. Androl. 10, 391 (2008).
18. Thevis M, Schänzer W. Current role of LC-MS(/MS) in doping control. Anal. Bioanal. Chem. 388, 1351 (2007).
19. Thevis M, Schänzer W. Mass spectrometric identification of peptide hormones in doping-control analysis. Analyst 132, 287 (2007).
20. Glotov AS, Dudkin PU. Modern techniques in gene research: prospect and applicability for the detection of gene doping. Presented at: The 3rd WADA Symposium on Gene Doping in Sports: From Gene and Therapy to Genetic Enhancement. St Petersburg, Russia, 10-11 June 2008.
21. Botrè F, Pavan A. Enhancement drugs and the athlete. Neurol. Clin. 26, 149 (2008).
22. World Anti-Doping Agency: The Accredited Laboratories. World Anti-Doping Agency, Montreal (Canada), 2008. www.wada-ama.org/en/dynamic.ch2?pageCategory. id=333 (Accessed 15th July 2008).
23. The World Anti-Doping Code. Laboratory Statistics. World Anti-Doping Agency, Montreal (Canada), 2008. www.wada-ama.org/en/dynamic.ch2?pageCategory. id=335 (Accessed 15th July 2008).